At Optibrium’s 2018 Drug Discovery Consultants’ Day, Dr Gareth Conduit from University of Cambridge and Intellegens Ltd. described their deep learning methods for predicting compound activities against protein targets based on sparse training data and presented early results of a collaboration with Optibrium.

You can download his slides as a PDF.